Aminopyrimidines useful as kinase inhibitors
US8557833B2 · kind B2 · utility
23Cited by
73References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 30, 2010 |
| Grant date | Oct 15, 2013 |
| Priority date | — |
| Expiry date | Jun 26, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to compounds useful as inhibitors of Aurora protein kinases. The invention also provides pharmaceutically acceptable compositions comprising those compounds and methods of using the compounds and compositions in the treatment of various disease, conditions, and disorders. The invention also provides processes for preparing compounds of the invention.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.